Drug intelligence / Profile preview

snake venom toxin

Development stage
Preclinical
Lead developer
Chungbuk National University
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Parenteral
01

Overview

Snake venom toxin (SVT) is a bioactive protein/peptide complex derived from snake venom (specifically associated with research from Chungbuk National University, often involving Vipera lebetina turanica) that exhibits potent anti-tumor activity. Its primary mechanism involves the inhibition of Nuclear Factor-kappa B (NF-κB) signaling, which leads to the up-regulation of death receptors, specifically Death Receptor 3 (DR3) and Death Receptor 5 (DR5). This induction of DRs sensitizes cancer cells to apoptosis and can overcome chemoresistance in various cancer types, including cervical, lung, and breast cancers. Preclinical studies have demonstrated its ability to inhibit tumor growth in vivo and enhance the susceptibility of chemoresistant cells to TNF-related apoptosis-inducing ligand (TRAIL).

Other names
snake venom
02

Targets

DR3 (Tumor necrosis factor receptor superfamily member 25)TNFRSF10B (DR5)

Beyond the preview

Go deeper on snake venom toxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on snake venom toxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call